Card image cap


COVID-19 Vaccine: Cancer and immunocompromised patients should receive the vaccine.   Icon Oncology strongly advises that people with cancer or a history of cancer should receive the COVID-19 vaccination.   Icon Oncology further recommends that cancer patients and survivors should be prioritised within Phase 2 of ...
Card image cap

SAJO receives DHET accreditation: Good news for cancer research in region.

The South African Journal of Oncology (SAJO) is proud to announce its recent accreditation received by the South African Department of Higher Education and Training (DHET). Announced in February this year, SAJO is now included in the list of accredited journals distributed by the Department. This ...
Card image cap

Mediclinic Southern Africa partners with Icon Oncology to offer a first in oncology.

New full-service oncology centre announced Cape Town, 24 March 2021: Leading value-based care (VBC) business, Icon Oncology and Mediclinic Southern Africa, today announced a first in South Africa partnership that aims to deliver seamless one-stop oncology services at a new flagship treatment facility based at Mediclinic ...
Card image cap

Icon Oncology Conference postponed to 3 – 5 June 2022

In light of the current trend and projected peak time of the COVID-19 pandemic in South Africa, Icon Oncology has concluded that it will not be possible to continue with plans of hosting the Icon 2020 Conference conference in October 2020. The Icon 2020 Conference organising ...
Card image cap

Patient care and staff well-being in oncology during the coronavirus pandemic – ethical considerations

An editorial on patient care and staff well-being during the corona virus pandemic has been published in the SA Journal of Oncology by Prof Raymond Abratt who is the Head of Clinical Governance at Icon Oncology. Icon Oncology continues to provide treatment and support to cancer ...
Card image cap

ASCO Guidelines to Improve Clinician Communication with Patients

Clear and effective communication is a core element of patient-centered oncology care.Oncology is a challenging field with high stakes and vulnerable patients. The treatment regimens used are often highly complex and may be toxic even at therapeutic doses. Oncology care is a multidisciplinary speciality. ...
Card image cap

TAILORx trial results – further clarity on the utility of the 21-gene assay in early breast cancer

The results of the TAILORx trial that were presented at the recent ASCO meeting and published in the NEJM in June will further assist in the clinical decision-making around adjuvant therapy in early breast cancer patients. (1) The uncertainty about the best treatment approach for women ...
Card image cap

Chemotherapy-Induced Nausea and Vomiting (CINV) – Guideline adherence for Low and Minimal Emetogenic Regimens

ICON supports appropriate and adequate anti-emesis for all patients receiving chemotherapy. This is crucial to improving quality of life during chemotherapy treatment and has an impact on patient outcomes (1). Modern antiemetic regimens have relegated chemotherapy induced nausea and vomiting (CINV) to a much less feared ...
Card image cap

Cervical Cancer Control in HIV infected woman past, present and future

We know that the incidence of both cervical dysplasia and neoplasia is significantly increased in HIV-infected women, and the prognosis is worse compared with HIV-uninfected women (Dryden-Peterson S, Bvochora-Nsingo M, Suneja G, Efstathiou JA et al. HIV Infection and Survival Among Women With Cervical Cancer. J ...
Card image cap

The ICON Clinical Team introduces the Royal College of Radiologists Radiotherapy Dose Fractionation 2nd Edition that was published in December 2016

The Faculty of Clinical Oncology of the Royal College of Radiologists published a comprehensive review on evidence-base Radiotherapy Dose Fractionation in December 2016. ...